JSC “Kalceks” starts production of tramadol injections
JSC “Kalceks” announces that the medicine “Tramadol-Kalceks 100mg/2ml solution for injection” has been approved by the State Agency of Medicines of the Republic of Latvia in June, this year. Active substance of the product is tramadol hydrochloride that works in certain areas of the brain and nervous system and is commonly used for treating of moderate to moderately severe pain.
In autumn this year, medicine will be available in Latvia for pharmaceutical products’ procurement organisations and hospitals, moreover – already during this year “Kalceks” plans to submit this product for registration also to other European Union countries as well as to CIS region and Middle East, where agreements are being concluded with cooperation partners.
JSC “Kalceks” Chairman of the Board Juris Hmelnickis: “We continue to develop and to offer for the market injectable forms, mostly for usage in hospitals, including during surgical manipulations and pain management. Tramadol-Kalceks is excellent supplementation of company portfolio, in such a way making this more attractive for partners and clients. For the next few years, “Kalceks” aim is significant expanding of injectables’ list that is already available for healthcare professionals in company’s web page www.kalceks.com section Products”.